Perha Pharmaceuticals
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phosphoproteomic Profile of Children With Down Syndrome (NCT06279208) | Perha Pharmaceuticals | 2024-03-18 |
| Leucettinib-21 First-in-Human Phase 1 in Healthy Volunteers and Subjects With Down Syndrome and Alzheimer's Disease (NCT06206824) | Perha Pharmaceuticals | 2024-01-18 |
Track Perha Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.